Reuters logo
BRIEF-Mast Therapeutics and Savara announce anticipated merger exchange ratio
2017年4月25日 / 中午12点16分 / 7 个月前

BRIEF-Mast Therapeutics and Savara announce anticipated merger exchange ratio

April 25 (Reuters) - Mast Therapeutics Inc

* Mast Therapeutics and Savara announce anticipated merger exchange ratio

* Each outstanding share of Savara common stock will be automatically converted into right to receive 0.5860 of share of Co’s common stock

* Merger currently is expected to close on or about April 27, 2017 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below